A study on tube replacement in patients with Parkinson's disease on Levodopa-Carbidopa Intestinal Gel (LCIG) therapy

A study on tube replacement in patients with Parkinson's disease on Levodopa-Carbidopa Intestinal Gel (LCIG) therapy - A study on tube replacement in patients with Parkinson's disease on LCIG therapy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000040713

Enrollment

Registered

2020-06-20

Start date

2020-05-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson&#39

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Subjects with Parkinson's disease on LCIG therapy in our hospital between October 2016 and April 2020, regardless of age or gender.

Exclusion criteria

Exclusion criteria: The subject has indicated that he/she will no longer participate in the study.

Design outcomes

Primary

Measure	Time frame
The rate of successful replacement of the PEG-J tube without endoscopy.	—

Secondary

Measure	Time frame
Type and incidence of complications associated with PEG-J tube replacement, time required for PEG-J tube replacement, and listing of reasons for not being able to replace a tube without endoscopy and the number of occurrences	—

Countries

Japan

Contacts

Public ContactYohei Mukai

National Center Hospital, National Center of Neurology and Psychiatry Department of neurology

ymukai@ncnp.go.jp+81-42-341-2711

Outcome results